EN IT

Reserved

Oscar Health at week six: 2 out of 3 targets hit, discipline calls for trimming

·43 min read
EXECUTIVE VIEW

Oscar Health at week 6 of the buy: 2 DL2 targets already hit, signal strength at 87 out of 100, stop at breakeven. The system flags the first management window: trim 34% of the position.

Reserved analysis Subscribe to read →
Reserved

Oracle approaching first window: a solid trade, not yet at the crossroads

·43 min read
EXECUTIVE VIEW

Oracle is in week 5 of an active BUY with signal strength 70 out of 100 and IQS Phase at 62, in ordinary phase. The stop is already at breakeven, risk is zeroed. 1 week to the first partial-reduction window.

Reserved analysis Subscribe to read →
Reserved

Orange SA: BUY at week one, but the confirmation stumbles

·43 min read
EXECUTIVE VIEW

Orange SA is in the first week of a buy signal. The confirmation week closed bearish: the system flags caution and the active stop is tighter than the structural level. Signal strength at 37 out of 100.

Reserved analysis Subscribe to read →
Reserved

L'Oreal Under Pressure: Signal Fading in Confirmation Week

·43 min read
EXECUTIVE VIEW

L'Oreal is in week 4 of an open buy with signal strength at 40 out of 100 and a bearish confirmation week. The signal remains active but fading: discipline calls for caution on the existing position.

Reserved analysis Subscribe to read →
Reserved

Opendoor Technologies: weak bearish pressure at the 1st sell signal

·42 min read
EXECUTIVE VIEW

Opendoor Technologies registers its 1st weekly sell signal with a signal strength of just 20 out of 100. Our model flags trading as not recommended: elevated-risk setup by our standards.

Reserved analysis Subscribe to read →
Reserved

Ondas Inc.: persistent sell signal, trading not recommended

·42 min read
EXECUTIVE VIEW

The sell signal on Ondas Inc. has been active for 16 weeks, with a strength of 37 out of 100. Our model flags trading as not recommended: opening at elevated risk, the asset remains under analysis.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn